Format

Send to

Choose Destination
Neuropharmacology. 2016 Nov;110(Pt B):633-643. doi: 10.1016/j.neuropharm.2015.10.010. Epub 2015 Oct 22.

Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Author information

1
Department of Biology, Georgetown University, Washington, D.C., USA; Interdisciplinary Program in Neuroscience, Georgetown University, Washington, D.C., USA.
2
Department of Biology, Georgetown University, Washington, D.C., USA.
3
Department of Biology, Georgetown University, Washington, D.C., USA; Interdisciplinary Program in Neuroscience, Georgetown University, Washington, D.C., USA. Electronic address: jh1659@georgetown.edu.

Abstract

Oligodendrocytes readily regenerate and replace myelin membranes around axons in the adult mammalian central nervous system (CNS) following injury. The ability to regenerate oligodendrocytes depends on the availability of neural progenitors called oligodendrocyte precursor cells (OPCs) in the adult CNS that respond to injury-associated signals to induce OPC expansion followed by oligodendrocyte differentiation, axonal contact and myelin regeneration (remyelination). Remyelination ensures the maintenance of axonal conduction, and the oligodendrocytes themselves provide metabolic factors that are necessary to maintain neuronal integrity. Recent advances in oligodendrocyte regeneration research are beginning to shed light on critical intrinsic signals, as well as extrinsic, environmental factors that regulate the distinct steps of oligodendrocyte lineage progression and myelin replacement under CNS injury. These studies may offer novel pharmacological targets for regenerative medicine in inflammatory demyelinating disorders in the CNS such as multiple sclerosis. This article is part of the Special Issue entitled 'Oligodendrocytes in Health and Disease'.

KEYWORDS:

Inflammation; Multiple sclerosis; Myelin; Oligodendrocyte precursor cells; Oligodendrocytes; Regeneration; Remyelination

PMID:
26474658
PMCID:
PMC4841742
DOI:
10.1016/j.neuropharm.2015.10.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center